Effective July 1, 2014, Senate File 2360 established Iowa Code chapter 124D, the Medical Cannabidiol Act, allowing for use of cannabidiol to treat intractable epilepsy. Cannabidiol is a nonpsychoactive cannabinoid found in the plan Cannabis sativa L. or Cannabis indica. The law allows patients to possess and use (but not to manufacture or sell) cannabidiol. The law also allows designated primary caregivers to possess cannabidiol on behalf of certain patients. Possession and use of cannabidiol requires the recommendation of a neurologist.
The Medical Cannabidiol Act directed the Iowa Department of Public Health, in collaboration with the Iowa Department of Transportation, to establish a process to approve and generate Cannabidiol Registration Cards for patients and their primary caregivers. Cannabidiol Registration Cards provide documentation that patients and primary caregivers have met the requirements of the Medical Cannabidiol Act Registration Card Program and are authorized to legally possess medically-necessary cannabidiol.
The Medical Cannabidiol Act allows oral or transdermal administration of cannabidiol oil containing no more than 3% tetrahydrocannabinol (THC). A patient may possess no more than 32 ounces of cannabidiol oil and primary caregivers may possess no more than 32 ounces of any cannabidiol oil for each patient.